Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. United States Pharmacopeia. USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Setting. Available at https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare. Last accessed February 15, 2026.
2. United States Pharmacopeia. USP <800> FAQs. Available at https://go.usp.org/l/323321/2020-06-26/3flhxs/323321/111087/USP_FAQs_on_GC_800.pdf. Last accessed February 15, 2026.
3. National Institute for Occupational Safety and Health. Managing Hazardous Drug Exposures: Information for Healthcare Settings. Available at https://www.cdc.gov/niosh/docs/2023-130/default.html. Last accessed February 15, 2026.
4. National Institute for Occupational Safety and Health. NIOSH List of Hazardous Drugs in Healthcare Settings, 2024. Available at https://www.cdc.gov/niosh/docs/2025-103/pdfs/2025-103.pdf?id=10.26616/NIOSHPUB2025103. Last accessed February 15, 2026.
5. National Institute for Occupational Safety and Health. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Setting, 2016. Available at https://archive.cdc.gov/#/details?q=https://www.cdc.gov/niosh/docs/2016-161/default.html. Last accessed February 15, 2026.
6. United States Environmental Protection Agency. Resource Conservation and Recovery Act (RCRA) Laws and Regulations. Available at https://www.epa.gov/rcra. Last accessed February 15, 2026.
7. Power LA, Coyne JW. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm. 2018;75:1996-2031.
8. United States Pharmacopeia. USP General Chapter <795> Pharmaceutical Compounding – Nonsterile Preparations. Available at https://www.usp.org/compounding/general-chapter-795. Last accessed February 15, 2026.
9. U.S. Food and Drug Administration. FDA Warns Against Using Treanda Injection (Solution) with Closed System Transfer Devices, Adapters, and Syringes Containing Polycarbonate or Acrylonitrile-butadiene-styrene; Provides List of Compatible Devices. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-against-using-treanda-injection-solution-closed-system-transfer-devices-adapters-and. Last accessed February 15, 2026.
10. Teva Pharmaceuticals USA, Inc. Prescribing Information: Bendeka (Bendamustine Hydrochloride) Injection, for Intravenous Use. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208194s000lbl.pdf. Last accessed February 15, 2026.
11. United States Pharmacopeia. USP General Chapter <797> Pharmaceutical Compounding – Sterile Preparations. Available at https://www.usp.org/compounding/general-chapter-797. Last accessed February 15, 2026.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.